Analysts fell to the sidelines weighing in on Equifax (EFX – Research Report) and Trane Technologies (TT – Research Report) with neutral ...

H.C. Wainwright reaffirmed its Buy rating and $50.00 price target for Akero Therapeutics (NASDAQ:AKRO), representing ...

Equifax (NYSE:EFX – Free Report) had its price objective decreased by Jefferies Financial Group from $340.00 to $300.00 in a ...

Akero Therapeutics (AKRO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ed Arce from ...

The Consumer Financial Protection Bureau (CFPB) has fined Equifax Inc. $15 million for failing to properly investigate ...

Equifax (NYSE:EFX) has been fined $15M by the Consumer Financial Protection Bureau (CFPB) for conducting inadequate ...

Equifax management has steered the company through a lengthy and onerous transition. Learn why EFX stock is a Buy.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Below is Validea's guru fundamental report for EQUIFAX INC (EFX). Of the 22 guru strategies we follow, EFX rates highest using our P/B Growth Investor model based on the published strategy of ...

Investors looking for stocks in the Consulting Services sector might want to consider either CRA International (CRAI) or Equifax (EFX). But which of these two companies is the best option for ...